Bracco Diagnostics, Inc clinical trials
A country office of Bracco
The registry lists 49 studies whose lead sponsor is Bracco Diagnostics, Inc. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.
Registry sponsor names on this page
- Bracco Diagnostics, Inc49 studies
Something wrong with this grouping? Tell us on the Bracco page.
Studies
Recruiting first, then most recently updated. Showing 49 of 49. All Bracco studies →
- Lumason® Infusion vs. Bolus AdministrationsRecruitingNCT06400004Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Thyroid Function of Pediatric Subjects Following Isovue® AdministrationTerminatedNCT03779906Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- BR55 in Characterization of Ovarian LesionsTerminatedNCT03493464Phase 2
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Transabdominal Ultrasound With BR55 for Characterization of Pancreatic LesionsTerminatedNCT03486327Phase 2
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Optimal Timing of BR55 CEUS of the OvariesTerminatedNCT04248153Phase 2
Sponsor listed in the registry: Bracco Diagnostics, Inc
- BR55 in Prostate Cancer: an Exploratory Clinical TrialCompletedNCT01253213Early Phase 1
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Renal MRA Crossover Study Comparing Multihance to Another Contrast AgentCompletedNCT00415805Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Study With Oral Isovue in Abdominopelvic CTCompletedNCT04453059
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142CompletedNCT02552238Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141CompletedNCT02522481Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate CancerCompletedNCT02142608Phase 1/2
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Multihance at 3 Tesla (3T) in Brain TumorsCompletedNCT00395863Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Kidney Damage in Patients With Moderate Fall in eGFRCompletedNCT01136876Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Evaluation of Gd Retention in Human Bone and Skin After MultiHance or ProHance Administration Compared With ControlCompletedNCT03108378
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Evaluation of Safety and Efficacy of Lumason in Pediatric EchocardiographyTerminatedNCT02282163Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrsCompletedNCT03750188
Sponsor listed in the registry: Bracco Diagnostics, Inc
- SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion CharacterizationCompletedNCT00829413Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS PatientsCompletedNCT03147989
Sponsor listed in the registry: Bracco Diagnostics, Inc
- SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion CharacterizationCompletedNCT00788697Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA)CompletedNCT02596048Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Crossover Comparison of MultiHance and DotaremCompletedNCT02070380Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Safety of SonoVue on Pulmonary HemodynamicsCompletedNCT01306292Phase 2
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Retrospective Study of MRI in Pediatric PatientsCompletedNCT02291822
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the BrainCompletedNCT01613417Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney DiseaseCompletedNCT00600834
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney DiseaseCompletedNCT00600951
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Kidney Damage In Patients With Severe Fall In eGFRTerminatedNCT01136915Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Kidney Damage in Patients With Normal eGFRCompletedNCT01137786Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Multidetector Computed Tomography (MDCT) Tailored ProtocolCompletedNCT01737333
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Isovue in Peripheral Digital Subtraction Angiography (DSA)CompletedNCT01075217Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Coronary MDCTA With Iopamidol Injection 370CompletedNCT00558792Phase 2
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)CompletedNCT00773409
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI ScanningCompletedNCT01424774
Sponsor listed in the registry: Bracco Diagnostics, Inc
- SonoVue Guided Prostate BiopsyTerminatedNCT00911027Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical SitesCompletedNCT01430975
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Patients With Renal Impairment Undergoing CTCompletedNCT00292487Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic PatientsTerminatedNCT00782639Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the BrainCompletedNCT00907530Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral ArteriesCompletedNCT01260636Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSACompletedNCT00740207Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Safety and Efficacy of MultiHance in Pediatric PatientsTerminatedNCT00323310Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Multihance Versus Magnevist in Breast MRICompletedNCT00486473Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Follow-up Study to Previous CARE TrialCompletedNCT00479024
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Crossover Study With MultiHance vs a Comparator for Peripheral MRACompletedNCT00408083Phase 3
Sponsor listed in the registry: Bracco Diagnostics, Inc
- A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the BrainCompletedNCT00323102Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- A Pharmacokinetics Study of MultiHance in Pediatric PatientsCompletedNCT00411931Phase 1
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)CompletedNCT00289614Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- Detection of Pulmonary Embolism With CECTCompletedNCT00351754Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc
- A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac AngiographyCompletedNCT00289029Phase 4
Sponsor listed in the registry: Bracco Diagnostics, Inc